The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study

Diabetic Medicine

Volumn 21, Issue 1, 2004, Pages 52-58

  Bonora, E ^a,b   Targher, G ^a   Formentini, G ^a   Calcaterra, F ^a   Lombardi, S ^a   Marini, F ^a   Zenari, L ^a   Saggiani, F ^a   Poli, M ^a   Perbellini, S ^a   Raffaelli, A ^a   Gemma, L ^a   Santi, L ^a   Bonadonna, R C ^a   Muggeo, M ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

Cardiovascular disease; Insulin resistance; Metabolic syndrome; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DEATH CERTIFICATE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; ECG ABNORMALITY; ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENDER; HEART MUSCLE ISCHEMIA; HUMAN; LEG ARTERY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PHYSICAL EXAMINATION; PREDICTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; VASCULAR DISEASE;

AGED; ALBUMINURIA; BLOOD GLUCOSE; CHOLESTEROL, HDL; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 10744221675     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01068.x     Document Type: Article

References (24)

1. Garg A, Grundy SM. Diabetic dyslipidemia and its therapy. Diabetes Rev 1987; 5: 425-433.
2. Fuller J. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985; 7: 3-7.
3. Juhan-Vague I, Alessi MC, Vague P. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 371-380.
4. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR et al. Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus (UKPDS 23). BMJ 1998; 316: 823-828.
5. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
6. Jokl R, Colwell JA. Arterial thrombosis and atherosclerosis in diabetes. Diabetes Rev, 1997; 5: 316-330.
7. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
8. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
9. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
10. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
11. Meigs JB, D'Agostino RB, Wilson PWF, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. Diabetes 1997; 46: 1594-1600.
12. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 1998; 47: 1643-1649.
13. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002; 25: 1135-41.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
15. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degree of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
16. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
17. Epstein FH, Ostrander LD, Johnson BC, Payne MW, Hayner NS, Keller JB et al. Epidemiological studies of cardiovascular diseases in a total community-Tecumseh, Michigan. Ann Intern Med 1965; 62: 1170-1187.
18. DeFronzo RA. The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
19. Lewis GF, Steiner G. Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 1996; 19: 390-393.
20. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 1993; 21: 129-135.
21. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 6: 434-444.
22. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
23. Lehto S, Rønnemaa T, Pyorala K, Laakso M. Cardiovascular risk factors clustering with endogenous hyperinsulinemia predict death from coronary heart disease in patients with type II diabetes. Diabetologia 2000; 43: 148-155.
24. Kuusisto J, Lempiainen P, Mykkanen L, Laakso M. Insulin Resistance Syndrome predicts coronary heart disease events in elderly type 2 diabetic men. Diabetes Care 2001; 24: 1629-1633.